Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Biol Blood Marrow Transplant 2020 Mar
Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation.
Related Questions
In patients with VOD post-HSCT, what would be the role of TPO agonists instead of platelet transfusions, given their platelet refractoriness and concerns for fluid overload?
New answer
by at Seattle Children’s Hospital (November 1, 2024)
This is an insightful question, as it addresses a key issue in the management of veno-occlusive disease (VOD) - chiefly, how does one minimize the amount of fluid being given,...
Read more (1 Answer available)
15828
×
To continue please login or register
Register
or
Sign in